Novel GM animal technologies and their governance

Transgenic Research

Volumn 22, Issue 4, 2013, Pages 681-695

  Bruce, Ann ^a   Castle, David ^a   Gibbs, Corrina ^a   Tait, Joyce ^a   Whitelaw, C Bruce A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Biotechnology; Company strategies; GM animals; Governance; Livestock; Regulatory science

Indexed keywords

ANIMAL; BIOTECHNOLOGY; DRUG INDUSTRY; ECONOMICS; EUROPEAN UNION; RESEARCH; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOTECHNOLOGY; DRUG INDUSTRY; ECONOMICS; EUROPEAN UNION; RESEARCH;

ANIMALIA;

EID: 84880510861     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-013-9724-5     Document Type: Review

References (85)

1. AFAA (2004) Biotechnology and animal production. AgriFood Awareness Australia.
2. Alexandratos N, Bruinsma J (2012) World Agriculture Trends 2030/2050. The 2012 Revision. ESA working paper no. 12-03. Food and Agriculture Organization of the United Nations. http://www. fao. org/docrep/016/ap106e/ap106e. pdf. Accessed 27 May 2013.
3. Bronzwaer S (2008) EFSA scientific forum 'from safe foods to healthy diets'. EU risk assessment-past, present and future. Trends Food Sci Technol 19: 52-58.
4. Brown N, Rappert B, Webster A, Cabello C, Sans-Menendez L, Markx F, van de Meulen B (2001) Final Report of the FORMAKIN Project, TSER Programme, Stage 2, Work Package 5/6, Jan, 2001. http://www. york. ac. uk/media/satsu/documents-papers/Brown-Rappert-2001-formakin. PDF. Accessed 9 April 2013.
5. Buck EH (2011) Genetically Engineered Fish and Seafood: Environmental Concerns. Congressional Research Service. Report for Congress.
6. Capecchi, MR (1989) Altering the genome by homologous recombination. Science 244: 1288-1292 PMID2660260.
7. Carlson DF, Wenfang Tan W, Lillico SG, Stverakovad D, Proudfoot C, Michelle Christiana M, Voytasa DF, Longf CR, Whitelaw CBA, Fahrenkrug SC (2012) Efficient TALEN-mediated gene knockout in livestock. PNAS 109(43): 17382-17387.
8. CAST (2009) Animal productivity and genetic diversity. Part 8, IP43.
9. Clark J, Whitelaw B (2003) A future for transgenic livestock. Nat Rev 4: 825-833.
10. Chataway J, Tait J, Wield D (2004) Understanding company R&D strategies in agro-biotechnology: trajectories and Blindspots. Res Policy 33(6-7): 1041-1057.
11. Codex Alimentarius (2008) Guideline for the conduct of food safety assessment of foods derived from recombinant DNA animals. http://www. codexalimentarius. org/codex-home/en/. Accessed 4 April 2013.
12. COGEM (2011) Genetically modified animals: a wanted and unwanted reality. COGEM Topic Report (CGM/120111-01) Independent scientific advice and information for the Dutch Government.
13. DeFrancesco L (2011) Move over ZFNs. Nat Biotechnol 29(7): 681-684.
14. Dove A (2000) Milking the genome for profit. Nat Biotechnol 18(10): 1045-1047.
15. Durai S, Mani M, Kandavelou K, Wu J, Porteus MH, Chandrasegaran S (2005) Zinc finger nucleases: custom designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res 33(18): 5978-5990.
16. EFSA Panels on GMO and AHAW (2012) Guidance on the risk assessment of food and feed from genetically modified animals and on animal health and welfare aspects. EFSA J 10(1): 2501-2544.
17. EFSA (2013) Guidance on the environmental risk assessment of genetically modified animals. EFSA J 11(5): 3200 http://www. efsa. europa. eu/en/efsajournal/pub/3200. htm?utm_source=feedly. Accessed 25 May 2013.
18. Ekser B, Edwin Klein E, Jing H, Stolz DB, Echeverri GJ, Long C, Lin CC, Mohamed E, Hidetaka H, Veroux M, Ayares D, Cooper DKC, Gridelli B (2012) Genetically engineered pig to baboon liver xenotransplantation: histopathology of xenografts and native organs. PLoS ONE 7(1): e29720.
19. Fahrenkrug SC, Blake A, Carlson DF, Doran T, van Eenennaam A, Faber D, Galli C, Gao Q, Hackett PB, Li N, Maga EA, Muir WM, Murray JD, Shi D, Stotish R, Sullivan E, Taylor JF, Walton M, Wheeler M, Whitelaw B, Glenn BP (2010) Precision genetics for complex objectives in animal agriculture. J Anim Sci 88: 2530-2539.
20. FAO (2009) The state of food and agriculture-livestock in the balance. Food and Agriculture Orgainzation of the United Nations, Rome.
21. FDA (2009) The Regulation of Genetically Engineered Animals containing Heritable Recombinant DNA constructs. Final Guidance.
22. FDA (2011) Advancing regulatory science at FDA: a strategic plan. August 2011. http://www. fda. gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719. htm. Accessed 17 March 2013.
23. FDA (2012) AquAdvantage salmon preliminary finding. Prepared by the Center for Veterinary Medicine, United States Food and Drug Administration Department of Health and Human Services. 4 May 2012 http://www. fda. gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEngineering/GeneticallyEngineeredAnimals/ucm280853. htm. Accessed 31 May 2013.
24. Fernandez M, Schook L (2005) Introduction. In A Future for Animal Biotechnology. Proceedings from a forum hosted by the University of Illinois and the Pew Initiative on Food and Biotechnology, Chicago, Illinois, Dec. 2005, pp 5-6 http://www. pewtrusts. org/uploadedFiles/wwwpewtrustsorg/Summaries_-_reports_and_pubs/PIFB_Future_for_Animal_Biotech_Workshop_Proceedings. pdf. Accessed 17 March 2013.
25. Foresight. The Future of Food and Farming (2011) Final Project Report. The Government Office for Science, London.
26. GAIN (2011) China-People's Republic of, GE plants and animals. Annual 2010. GAIN report number CH11002. USDA Global Agricultural Information Network. http://gain. fas. usda. gov/pdf. Accessed 31 May 2013.
27. Garnett T (2009) Livestock-related greenhouse gas emissions: impacts and options for policy makers. Environ Sci Policy 12: 491-503.
28. Gaskell G, Allansdottir A, Allum N, Castro P, Esmer Y, Fischler C, Jackson J, Kronberger N, Hampel J, Mejlgaard N, Quintanvilha A, Rammer A, Revuelta G, Stares S, Torgersen H, Wager W (2011) The 2010 Eurobarometer on the life sciences. Nat Biotechnol 29(2): 113-114.
29. Golovan SP, Meidinger RG, Ajakaiye A, Cottrill M, Wiederkehr M, Barney D, Plante C, Pollard J, Fan MZ, Hayes MA, Laursen J, Hjorth JP, Hacker RR, Phillips JP, Forsberg CW (2001) Pigs expressing salivary phytase and acid phosphatase activities. Can J Microbiol 46: 59-71.
30. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77: 7380-7384.
31. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A (2009) Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325(5939): 433.
32. Health Canada (2011) The Regulation of genetically modified food. http://www. hc-sc. gc. ca/sr-sr/pubs/biotech/reg_gen_mod-eng. php. Accessed 4 March 2013.
33. Houdebine L-M (2009) Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 32(2): 107-121.
34. Huang J, Wang Q (2002) Agricultural biotechnology development and policy in China. AgBioForum 5(4): 122-131.
35. Hume DA, Whitelaw CBA, Archibald AL (2011) The future of animal production; improving productivity and sustainability. J Agric Sci 149: 9-16.
36. Ittner LM, Gotz J (2007) Pronuclear injection for the production of transgenic mice. Nat Protoc 2: 1206-1215.
37. Jabed A, Wagner S, McCraken J, Wells DW, Laible G (2012) Targeted microRNA expression in dairy cattle directs production of β-lactoglobulin-free high-casein milk. Proc Nat Acad Sci USA 109(42): 16811-16816.
38. Kaneko T, Moisyadi S, Suganuma R, Hohn B, Yanagimachi R, Pelczar P (2005) Recombinase-mediated mouse transgenesis by intracytoplasmic sperm injection. Theriogenology 64: 1704-1715.
39. Kleter GA, Kok EJ (2010) Safety assessment of biotechnology used in animal production, including Genetically Modified (GM) feed and GM animals-a review. Animal Sci Pap Rep 28(2): 105-114.
40. Lazaris A, Arcidiacono S, Huang Y, Zhou J-F, Duguay F, Chretien N, Welsh EA, Soareas W, Karatzas CN (2002) Spider silk fibers spun from soluble recombinant silk produced in mammalian cells. Science 295: 472-476.
41. Le Provost F, Lillico S, Passet B, Young R, Whitelaw B, Vilotte J-L (2009) Zinc finger nuclease technology heralds a new era in mammalian transgenesis. Trends Biotechnol 28(3): 134-141.
42. Lusser M, Davies HV (2013) Comparative regulatory approaches for groups of new plant breeding techniques. New Biotechnol (in press) http://dx. doi. org/10. 1016/j. nbt. 2013. 02. 004.
43. Lyall J, Irvine RA, Sherman A, McKinley TJ, Nunez A, Purdie A, Outtrim L, Brown IH, Rolleston-Smith G, Sang H, Tiley L (2011) Suppression of avian influenza transmission in genetically modified chickens. Science 33: 223-226.
44. Maga EA, Murray JD (2010) Welfare applications of genetically engineered animals for use in agriculture. J Anim Sci 88: 1588-1591.
45. Mandel GN (2004) Gaps, inexperience, inconsistencies and overlaps: crisis in the regulation of genetically modified plants and animals. William Mary Law Rev 45: 2167-2260.
46. Marshall KM, Hurley WL, Shanks RD, Wheeler MB (2006) Effects of suckling intensity on milk yield and piglet growth from lactation-enhanced gilts. J Anim Sci 84: 2346-2351.
47. Martineau B (2001) First Fruit. The creation of the Flavr Savr™ tomato and the birth of biotech food. McGraw-Hill, New York
48. Mastroeni M, Tait J, Rosiello A (2013) Regional innovation policies in a globally connected environment. Sci Public Policy 40(1): 8-16.
49. Mastroeni M, Mittra J, Tait J (2012) Methodology for the Analysis of Life Science Innovation Systems (ALSIS) and its Application to Three Case Studies. TSB Regenerative Medicine Programme: Value Systems and Business Models. REALISE Project. Innogen Centre Report to Technology Strategy Board. 29th May, 2012. http://www. genomicsnetwork. ac. uk/media/REALISE%20Case%20Study%20Report%20-%20Innogen. pdf. Accessed 4 April 2013.
50. McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H (2004) Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 5: 728-733.
51. Mendon A-Hagler L, Souza L, Aleixo L, Oda L (2008) Trends in biotechnology and biosafety in Brazil. Environ Biosafety Res 7: 115-121.
52. Mittra J, Tait J, Wield D (2011) From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries. Trends Biotechnol 29(3): 105-109.
53. Milne CP, Tait J (2009) Evolution along the government-governance continuum: FDA'S orphan products and fast track programs as exemplars of "what works" for innovation and regulation. Food and Drug Law J 64(4): 733-753.
54. Mittra J, Tait J (2012) Analysing stratified medicine business models and value systems: innovation-regulation interactions. New Biotechnol 29(6): 709-719.
55. Murray JD, Maga EA (2010) Is there a risk from not using GE animals? Transgenic Res 19: 357-361.
56. Murray JD, Mohamad-Fauzi N, Cooper CA, Maga EA (2010) Current status of transgenic animal research for human health applications. Acta Sci Vet 38(2): 627-632.
57. Niemann H, Kues W, Carnwath JW (2009) Transgenic farm animals: present and future. Rev Sci Tech 24: 285-298.
58. Noyes H, Brass A, Obara I, Anderson S, Archibald AL, Bradley DG, Fisher P, Freeman A, Gibson J, Gicheru M, Hall L, Hanotte O, Hulme H, McKeever D, Murray C, Oh SJ, Tate C, Smith K, Tapio M, Wambugo J, Williams DJ, Agaba M, Kemp SJ (2011) Genetic and expression analysis of cattle identifies candidate gene in pathways responding to Trypanosoma congolense infection. Proc Natl Acad Sci 108(22): 9304-9309.
59. Novosleva TA, Meuwissen MPM, Huirne RBM (2007) Adoption of GM technology in livestock production chains: an integrating framework. Trends Food Sci Technol 18: 175-188.
60. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300: 611-615.
61. Park F (2007) Lentiviral vectors; are they the future of animal transgenesis? Physiol Genomics 31: 159-173.
62. Pig Progress (2012) Enviropig project halted as Ontario Pork pulls the plug. http://www. pigprogress. net/Health-Diseases/Research/2012/4/Enviropig-project-halted-as-Ontario-Pork-pulls-the-plug-PP008578W/. Accessed 4 April 2012.
63. Pray L (2008) Recombinant DNA technology and transgenic animals. Nature Education 1(1).
64. Regaldo A (2010) Building a Better Goat. MIT Technology Review. http://www. technologyreview. com/news/421268/building-a-better-goat/. Accessed 10 March 2013.
65. Ridley M (2013) Editing our Genes, One Letter at a Time. The Wall Street Journal, Mind and Matter. January 11th.
66. Salamone D, Barañao L, Santos C, Bussmann L, Artuso J, Werning C, Prync A, Carbonetto C, Dabsys S, Munar C, Salaberry R, Berra G, Berra I, Fernández N, Papouchado M, Foti M, Judewicz N, Mujica I, Muñoz L, Alvarez SF, González E, Zimmermann J, Criscuolo M, Melo C (2006) High level expression of bioactive recombinant hormone growth hormone in the milk of transgenic cows. J Biotechnol 124(2): 46-72.
67. Schnieke AE, Kind AJ, Ritchie WA, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A, Campbell KH (1997) Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278: 2130-2133.
68. Service F (2002) Mammalian cells spin a spidery new yarn. Science 295(5554): 419-421.
69. Subramanian V (2012) Driving forces in global agriculture. Rice Today-International Rice Research Institute. 11(2): 40-41.
70. Suk J, Bruce A, Gertz R, Whitelaw CBA, Braun A, Oram C, Rodriguez-Cerezo E, Papatryfon I (2007) Dolly for dinner? Assessing commercial and regulatory trends in cloned livestock. Nat Biotechnol 25(1): 47-53.
71. Tait J (2007) Systemic interactions in life science innovation. Technol Anal Strateg Manag 19(3): 257-277.
72. Tait J (2008) Risk governance of genetically modified crops: European and American perspectives. In: Renn O, Walker K (eds) Global risk governance: concept and practice using the IRGC framework. Springer Science and Business Media, Dordrecht, pp 133-153.
73. Tait J, Barker G (2011) Global food security and the governance of modern biotechnologies: opportunities and challenges for Europe. EMBO Rep 12: 763-768.
74. Tait J, Levidow L (1992) Proactive and reactive approaches to risk regulation: the case of biotechnology. Futures 24(3): 219-231.
75. Tait J, with Wield D, Chataway J, Bruce A (2008) Health Biotechnology to 2030. Report to OECD International Futures Project, "The Bio-Economy to 2030: Designing a Policy Agenda", OECD, Paris, pp 51; http://www. oecd. org/dataoecd/12/10/40922867. pdf. Accessed 4 April 2013.
76. Tomley FM, Shirley MW (2009) Livestock infectious diseases and zoonoses. Philos Trans R Soc B 364: 2637-2642.
77. van Eenennaam AL, Muir WM (2011) Transgenic salmon: a final leap to the grocery shelf. Nat Biotechnol 29(8): 706-7011.
78. Vàzquez-Salat N, Salter B, Smets G (2010) International Multi-level Governance of Genetically Modified Organisms: EU, USA and India. Work Package 6: Activity 6. 1. PEGASUS.
79. Vàzquez-Salat N, Houdebine LM (2013) Will GM animals follow the GM plant fate? Transgenic Res 22: 5-13.
80. Vàzquez-Salat N, Salter B, Smets G, Houdebine LM (2012) The current state of GMO governance: are we ready for GM animals? Biotechnol Adv 30: 1336-1343.
81. Waigmann E, Paoletti C, Davies H, Perry J, Kärenlampi S, Kuiper H (2012) Risk assessment of genetically modified organisms (GMOs). EFSA J 10(10) s1008: 1-7 http://www. efsa. europa. eu/en/efsajournal/pub/s1008. htm. Accessed 31 May 2013.
82. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/cas-mediated genome engineering. Cell 153(4): 910-918.
83. World Trade Organization (WTO) (2010) European communities-measures affecting the approval and marketing of biotech products. http://www. wto. org/english/tratop_e/dispu_e/cases_e/ds291_e. htm. Accessed 27 May 2013.
84. Yang W (2003) Regulation of genetically modified organisms in China. RECIEL 12(1): 99-108.
85. Yang B, Wang J, Tang B, Liu Y, Guo C, Yang P, Yu T, Li R, Zhao J, Zhang L, Dai Y, Li N (2011) Characterisation of bioactive recombinant human lysozyme expressed in milk of transgenic cattle. PLoS ONE 6(3): 1-10.